Amgen (AMGN) Dividends Paid - Common (2011 - 2026)
Amgen (AMGN) posted quarterly Dividends Paid - Common of $1.4 billion for Q1 2026, up 6.18% year-over-year from $1.3 billion in Q1 2025, and up 5.85% on a QoQ basis from $1.3 billion in Q4 2025.
Amgen (AMGN) Dividends Paid - Common (2011 - 2026) Analysis & Trends
Amgen (AMGN) has reported Dividends Paid - Common for 16 consecutive years, with $1.4 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Dividends Paid - Common rose 6.18% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $5.2 billion (up 6.12% YoY), while the FY2025 annual figure was $5.1 billion, up 6.04% from the prior year.
- Dividends Paid - Common came in at $1.4 billion for Q1 2026 at Amgen, up from $1.3 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was $1.4 billion in Q1 2026, with the low at $1.0 billion in Q2 2022.
- Average Dividends Paid - Common over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
- Across the five-year window, Dividends Paid - Common grew 2.98% in 2022 and grew 9.83% in 2023, its largest moves.
- Year by year, Dividends Paid - Common stood at $1.0 billion in 2022, then gained by 9.62% to $1.1 billion in 2023, then advanced by 5.7% to $1.2 billion in 2024, then grew by 6.47% to $1.3 billion in 2025, then advanced by 5.85% to $1.4 billion in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $1.4 billion, $1.3 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.36 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.14 Bn |
| Dec 31, 2023 | 1.14 Bn |